Cargando…
T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
Almost 30 years ago, Carlo Croce's group discovered the T-Cell Leukemia/Lymphoma 1A oncogene (TCL1A or TCL1). TCL1 protein is normally expressed in fetal tissues and early developmental stage lymphocytes. Its expression is deregulated in chronic lymphocytic leukemia (B-CLL) and most lymphomas....
Autores principales: | Paduano, Francesco, Gaudio, Eugenio, Mensah, Afua A., Pinton, Sandra, Bertoni, Francesco, Trapasso, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099186/ https://www.ncbi.nlm.nih.gov/pubmed/30151355 http://dx.doi.org/10.3389/fonc.2018.00317 |
Ejemplares similares
-
The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90
por: Paduano, Francesco, et al.
Publicado: (2022) -
The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016) -
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014) -
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells
por: Gaudio, Eugenio, et al.
Publicado: (2016) -
Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells
por: Miyazaki, Tatsushi, et al.
Publicado: (2013)